Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients

Gender Medicine

Volumn 8, Issue 2, 2011, Pages 93-102

  Rasul, Sazan ^a   Ilhan, Aysegul ^a   Reiter, Marie Helene ^a   Baumgartner Parzer, Sabina ^a   Kautzky Willer, Alexandra ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

adiponectin; gender; sex hormones; type 2 diabetes

Indexed keywords

ADIPONECTIN; C PEPTIDE; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; SEX HORMONE BINDING GLOBULIN; SULFONYLUREA; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; ESTRADIOL BLOOD LEVEL; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INDEX FOR INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADIPONECTIN; ADULT; AGE FACTORS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ESTRADIOL CONGENERS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PROGESTERONE CONGENERS; SEX FACTORS; SEX HORMONE-BINDING GLOBULIN; STATISTICS AS TOPIC; TESTOSTERONE CONGENERS;

EID: 79955637774     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2011.01.004     Document Type: Article

References (39)

1. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-1935. (Pubitemid 32472900)
2. Gastaldelli A, Kozakova M, Højlund K, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology. 2009;49:1537-1544.
3. Adamczak M, Rzepka E, Chudek J, Wiecek, A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf). 2005;62:114-118. (Pubitemid 40175291)
4. Spranger J, Möhlig M, Wegewitz U, et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2004;61:738-746. (Pubitemid 40006795)
5. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care. 2003;26:2015-2020. (Pubitemid 41184244)
6. Golden SH, Dobs AS, Vaidya D, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab. 2007;92:1289-1295. (Pubitemid 46556400)
7. Ding EL, Song Y, Manson JE, et al. Sex hormonebinding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361:1152-1163.
8. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab. 2003;88:1646-1652. (Pubitemid 36623382)
9. Haffner SM, Valdez RA, Mykkänen L, et al. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism. 1994;43:599-603. (Pubitemid 24145467)
10. Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27:1036-1041. (Pubitemid 38579762)
11. Yasui T, Tomita J, Miyatani Y, et al. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations. Clin Chim Acta. 2007;386:69-75. (Pubitemid 47417965)
12. Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond). 2007;31:457-465.
13. Södergård R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem. 1982;16:801-810. (Pubitemid 13228095)
14. Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
15. Undén AL, Elofsson S, Andréasson A, et al. Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. Gend Med. 2008;5:162-180. (Pubitemid 351843224)
16. Legato MJ, Gelzer A, Goland R, et al. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med. 2006;3:131-158. (Pubitemid 44069479)
17. Schulze MB, Rimm EB, Shai I, et al. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004;27:1680-1687. (Pubitemid 38857444)
18. Fernández-Real JM, Botas-Cervero P, Lápez-Bermano A, et al. Adiponectin is independently associated with glycosylated haemoglobin. Eur J Endocrinol. 2004;150:201-205. (Pubitemid 38331903)
19. Al-Ghamdi, A.A. Role of HbA1c in management of diabetes mellitus. Saudi Med J. 2004;25:342-345. (Pubitemid 38461099)
20. Lee, JM, Kim SR, Yoo SJ, et al. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res. 2009;37:1803-1812.
21. Tsujimura A, Takada S, Matsuoka Y, et al. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link? Int J Urol. 2009;16:830-835.
22. Muller M, Grobbee DE, den Tonkelaar I, et al. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90:2618-2623. (Pubitemid 40686299)
23. Makhsida N, Shah J, Yan G, et al. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005;174:827-834. (Pubitemid 41140604)
24. Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2009;94:4776-4784.
25. Marin P, Holmäng S, Jonsson L, et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord. 1992;16:991-997. (Pubitemid 23010023)
26. Kapoor D, Clarke S, Stanworth R, et al. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007;156:595-602. (Pubitemid 46796527)
27. Heufelder AE, Saad F, Bunck MC, Gooren L. Fiftytwo- week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl. 2009;30:726-733.
28. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6:1-7. (Pubitemid 36606394)
29. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010:363:109-122.
30. Jorsal A, Tarnow L, Frystyk J, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008;74:649-654.
31. Pagano C, Soardo G, Esposito W, et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol. 2005;152:113-118. (Pubitemid 40185459)
32. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815-3819. (Pubitemid 32755982)
33. Nakanishi N, Suzuki K, Tatara K. Serum gammaglutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004;27:1427-1432. (Pubitemid 38679993)
34. Shin JY, Chang SJ, Shin YG, et al. Elevated serum gamma- glutamyltransferase levels are independently associated with insulin resistance in nondiabetic subjects. Diabetes Res Clin Pract. 2009;84:152-157.
35. Kral JG, Schaffner F, Pierson RN Jr, Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism. 1993;42:548-551. (Pubitemid 23141622)
36. Li H, Wang YJ, Tan K, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int. 2009;8:377-382.
37. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010:28:155-161.
38. Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54:3541-3546. (Pubitemid 43334347)
39. Prikoszovich T, Winzer C, Schmid AI, et al. Body and liver fat mass rather fhan muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes. Diabetes Care. 2011;34:430-436.